Oliver von Stein
Chief Executive Officer & Co-founder @Apta Therapeutics Gmbh
Signup · Get unlimited contacts
WORK HISTORY
Chief Executive Officer & Co-founder @Apta Therapeutics Gmbh
Berlin, DE
APTA Therapeutics is a pioneering clinical-stage biopharmaceutical company dedicated to transforming the treatment of diseases caused by regulatory autoantibodies.Building on cutting-edge research from Berlin’s renowned Charité and Max Delbrück Center, we harness the power of DNA-based aptamers that precisely target and neutralize pathogenic regulatory autoantibodies.
EDUCATION
University of Southampton
MSc, Pharmacology
Liverpool John Moores University
BSc, Biochemistry
Karlsruhe Institute of Technology (KIT)
PhD, Molecular Biology (Oncology)
SKILLS
ABOUT OLIVER VON STEIN
Currently, the CEO of APTA Therapeutics, a compnay dedicated to innovation and impactful science and committed to improving global health through life-changing therapies. With over two decades of experience in the life sciences industry. Previously founder of vS Health Technologies GmbH (2017), Founder & CEO of iModia Biotech GmbH (2016), and co-founder/CSO/ of InDex Pharmaceuticals AB, Sweden (2001, Nasdaq, 2016), a company focused on the development of Nucleic Acid (NA) based drugs and diagnostics. Consider myself seasoned business development professional, driving innovative NA therapies and diagnostic product development across various therapeutic areas, including autoimmune, inflammatory diseases, and oncology, with a track record in closing deals worth over 250 million euros and raising over 90 million euros in equity capital.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.